ArticleRSC advances2019

Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer:

Mantosh Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.